- Home
- PMT vs PCRX Comparison
PMT vs PCRX Comparison
Compare PMT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- PCRX
- Stock Information
- Founded
- PMT 2009
- PCRX 2006
- Country
- PMT United States
- PCRX United States
- Employees
- PMT N/A
- PCRX N/A
- Industry
- PMT Real Estate Investment Trusts
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- PCRX Health Care
- Exchange
- PMT Nasdaq
- PCRX Nasdaq
- Market Cap
- PMT 1.1B
- PCRX 1.2B
- IPO Year
- PMT 2009
- PCRX 2011
- Fundamental
- Price
- PMT $11.84
- PCRX $23.15
- Analyst Decision
- PMT Hold
- PCRX Buy
- Analyst Count
- PMT 6
- PCRX 5
- Target Price
- PMT $14.20
- PCRX $32.40
- AVG Volume (30 Days)
- PMT 859.5K
- PCRX 443.2K
- Earning Date
- PMT 10-21-2025
- PCRX 11-05-2025
- Dividend Yield
- PMT 13.65%
- PCRX N/A
- EPS Growth
- PMT N/A
- PCRX N/A
- EPS
- PMT 0.72
- PCRX N/A
- Revenue
- PMT $614,826,000.00
- PCRX $705,848,000.00
- Revenue This Year
- PMT N/A
- PCRX $7.36
- Revenue Next Year
- PMT $27.87
- PCRX $10.07
- P/E Ratio
- PMT $16.29
- PCRX N/A
- Revenue Growth
- PMT 13.07
- PCRX 2.25
- 52 Week Low
- PMT $11.60
- PCRX $16.00
- 52 Week High
- PMT $14.93
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- PMT 42.67
- PCRX 39.75
- Support Level
- PMT $11.60
- PCRX $22.63
- Resistance Level
- PMT $12.11
- PCRX $26.05
- Average True Range (ATR)
- PMT 0.25
- PCRX 0.77
- MACD
- PMT -0.06
- PCRX -0.09
- Stochastic Oscillator
- PMT 21.03
- PCRX 28.04
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.